Efficacy of topical 5-Fluorouracil in the management of ocular surface squamous neoplasia: a study of 101 eyes
International Ophthalmology · 2024
DOI: 10.1007/s10792-024-03182-x ↗Kurz gefasst
Fachartikel in der Zeitschrift International Ophthalmology, 2024. Verfasst von Komal Bakal und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Operation Eyesight Universal Institute for Eye Cancer, LV Prasad Eye Institute, L V Prasad Marg, Road No 2, Banjara Hills, Hyderabad, 500034, Ind…. Hauptthemen laut MEDLINE: Fluorouracil, Antimetabolites, Antineoplastic, Ophthalmic Solutions, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Hyderabad Eye Research Foundation.
Abstract (Originalsprache)
OBJECTIVE: To study the efficacy and side-effect profile of topical 5-Fluorouracil (5-FU) in the treatment of ocular surface squamous neoplasia (OSSN). METHODS: Retrospective study of 101 eyes of 100 patients treated with 5-FU with one week on and 3 weeks off regimen. RESULTS: Of the 100 patients (101 eyes), the mean age at diagnosis of OSSN was 49 (median, 52 years; range, 11-87 years). History of prior intervention was noted in 6 (6%) eyes. Tumor epicenter included bulbar conjunctiva (n = 54; 53%), limbus (n = 27; 27%), and cornea (n = 20;20%). Mean number of cycles of topical 5-FU administered was 3 (median, 3; range, 1-8). Complete tumor regression was achieved with topical 5-FU in 89 (88%) eyes with a mean number of 2 cycles (median, 2; range, 1-6) of 5-FU. The remaining 12 (12%) lesions underwent additional treatment including excisional biopsy (n = 7), extended enucleation (n = 3), and topical Interferon alpha 2b (n = 2) for complete tumor control. Over a mean follow-up period of 6 months (median, 5 months; range, 1-36 months) following treatment, tumor recurrence was noted in 2 (2%) patients, and side-effects were noted in 7 (7%) eyes including conjunctival hyperemia (n = 1), punctal stenosis (n = 1), sterile keratitis (n = 4), and limbal stem cell deficiency (n = 1). CONCLUSION: Topical 5-FU is an effective non-invasive therapy for OSSN with a minimal side-effect profile.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Operation Eyesight Universal Institute for Eye Cancer, LV Prasad Eye Institute, L V Prasad Marg, Road No 2, Banjara Hills, Hyderabad, 500034, India.
- Hima Bindu Yalamanchali Center for Eye Cancer, LV Prasad Eye Institute, Vijayawada, India.
- The Operation Eyesight Universal Institute for Eye Cancer, LV Prasad Eye Institute, L V Prasad Marg, Road No 2, Banjara Hills, Hyderabad, 500034, India. kalikiswathi@yahoo.com.
ORCID-Profile: Swathi Kaliki
Förderung
- Hyderabad Eye Research Foundation
Zitieren
APA
Bakal, K., Molugu, S., Machakuri, K., Bejjanki, K. M., Kapoor, A. G., & Kaliki, S. (2024). Efficacy of topical 5-Fluorouracil in the management of ocular surface squamous neoplasia: a study of 101 eyes. International Ophthalmology. https://doi.org/10.1007/s10792-024-03182-x
Vancouver
Bakal K, Molugu S, Machakuri K, Bejjanki KM, Kapoor AG, Kaliki S. Efficacy of topical 5-Fluorouracil in the management of ocular surface squamous neoplasia: a study of 101 eyes. International Ophthalmology. 2024. doi:10.1007/s10792-024-03182-x
BibTeX
@article{Bakal2024,
author = {Bakal, Komal and Molugu, Sanjana and Machakuri, Khaleel and Bejjanki, Kavya Madhuri and Kapoor, Anasua Ganguly and Kaliki, Swathi},
title = {Efficacy of topical 5-Fluorouracil in the management of ocular surface squamous neoplasia: a study of 101 eyes},
journal = {International Ophthalmology},
year = {2024},
doi = {10.1007/s10792-024-03182-x}
}
EUVIMED